Plasmanate (GRIFOLS USA, LLC)


Welcome to the PulseAid listing for the Plasmanate drug offered from GRIFOLS USA, LLC. This Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: GRIFOLS USA, LLC
NON-PROPRIETARY NAME: Plasma Protein Fraction (Human)
SUBSTANCE NAME: ALBUMIN HUMAN
TYPE: PLASMA DERIVATIVE
PHARMA CLASS: Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1958-10-02
END MARKETING DATE: 0000-00-00


Plasmanate PLASMA DERIVATIVE Details:

Item DescriptionPlasmanate from GRIFOLS USA, LLC
LABELER NAME: GRIFOLS USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 2.5(g/50mL)
START MARKETING DATE: 1958-10-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 13533-613_21e1da7a-a24e-4949-8923-e70f6f490bf8
PRODUCT NDC: 13533-613
APPLICATION NUMBER: BLA101140

Other ALBUMIN HUMAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxalta US Inc.Buminate
CSL Behring AGAlbuRx
GRIFOLS USA, LLCALBUTEIN
KEDRION BIOPHARMA, INC.Albuked